Dare Bioscience (DARE) Price to Book (2017 - 2026)

Dare Bioscience (DARE) has reported Price to Book for 10 consecutive years, with 57.15 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book fell 3271.5% year-over-year to 57.15; the trailing twelve-month figure through Jun 2026 stood at 57.15 (down 3271.5% YoY), and the FY2025 full-year result was 7.59, up 268.1% from the prior year.
• Price to Book slipped to 57.15 in Q2 2026 per DARE's latest filing, from 7.59 in the prior quarter.
• Across five years, Price to Book topped out at 18.03 in Q1 2023 and bottomed at 57.15 in Q2 2026.
• Historically, Price to Book has averaged 4.63 across 5 years, with a median of 1.69 in 2025.
• The sharpest annual moves came in 2023 and 2026: Price to Book surged 345.07% in 2023, then plunged 3271.5% in 2026.
• Over 5 years, Price to Book stood at 6.34 in 2022, then slumped by 196.59% to 6.12 in 2023, then increased by 26.22% to 4.52 in 2024, then surged by 268.1% to 7.59 in 2025, then plunged by 852.94% to 57.15 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 57.15, 7.59, and 10.24 for Q2 2026, Q4 2025, and Q3 2025 respectively.